| 1 |
Zhou LM, Fan JH, Xu MM, Xiong MY, Wang QJ, Chai X, Li XD, Li XG, Ye XL. Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis. Biochim Biophys Acta Mol Basis Dis 2023;1869:166639. [PMID: 36638873 DOI: 10.1016/j.bbadis.2023.166639] [Reference Citation Analysis]
|
| 2 |
Tian G, Wang W, Xia E, Chen W, Zhang S. Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota. Front Cell Infect Microbiol 2023;13:1078447. [PMID: 36860985 DOI: 10.3389/fcimb.2023.1078447] [Reference Citation Analysis]
|
| 3 |
Huang L, Xu Y, Lai Z, Zhou Z, Deng M. The anti-hepatic fibrosis effects of chlorogenic acid extracted from Artemisia Capillaris Herba on CCl4-induced mice via regulating TGF-β1/smad3 pathway. Pharmacological Research - Modern Chinese Medicine 2023. [DOI: 10.1016/j.prmcm.2023.100227] [Reference Citation Analysis]
|
| 4 |
Fang QL, Qiao X, Yin XQ, Zeng YC, Du CH, Xue YM, Zhao XJ, Hu CY, Huang F, Lin YP. Flavonoids from Scutellaria amoena C. H. Wright alleviate mitochondrial dysfunction and regulate oxidative stress via Keap1/Nrf2/HO-1 axis in rats with high-fat diet-induced nonalcoholic steatohepatitis. Biomed Pharmacother 2023;158:114160. [PMID: 36571996 DOI: 10.1016/j.biopha.2022.114160] [Reference Citation Analysis]
|
| 5 |
Wu L, Lu Z, He B, Yu J, Yan M, Jiang J, Chen Z. Pure total flavonoids from citrus improve nonalcoholic steatohepatitis liver inflammatory responses by regulating the CCL2 / CCR2‐PI3K‐Akt signal transduction pathway. The Anatomical Record 2022. [DOI: 10.1002/ar.25117] [Reference Citation Analysis]
|
| 6 |
Zhu M, Jia Z, Yan X, Liu L, Fang C, Feng M, Dai Y, Zhang Y, Wu H, Huang B, Li Y, Liu J, Xiao H. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK. J Ethnopharmacol 2022;295:115427. [PMID: 35654350 DOI: 10.1016/j.jep.2022.115427] [Reference Citation Analysis]
|
| 7 |
Tan YY, Yue SR, Lu AP, Zhang L, Ji G, Liu BC, Wang RR. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis. Phytomedicine 2022;103:154208. [PMID: 35691078 DOI: 10.1016/j.phymed.2022.154208] [Reference Citation Analysis]
|
| 8 |
Jia W, Wang K, Zhang S, Lu W, Du A, Li J, Ji L, Xu H. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease. Phytomedicine 2022;104:154326. [PMID: 35853303 DOI: 10.1016/j.phymed.2022.154326] [Reference Citation Analysis]
|
| 9 |
Yang H, Feng L, Xu L, Jiang D, Zhai F, Tong G, Xing Y, Wada K. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/4801695] [Reference Citation Analysis]
|
| 10 |
Sun X, Huang Y, Zhu S, Yan J, Gan K, Xu Z, Wang S, Kang X, Zhang J, Sun W. Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation. Drug Des Devel Ther 2022;16:769-87. [PMID: 35355655 DOI: 10.2147/DDDT.S348335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Cui HR, Zhang JY, Cheng XH, Zheng JX, Zhang Q, Zheng R, You LZ, Han DR, Shang HC. Immunometabolism at the service of traditional Chinese medicine. Pharmacol Res 2022;:106081. [PMID: 35033650 DOI: 10.1016/j.phrs.2022.106081] [Reference Citation Analysis]
|
